NguyenKNAFCI.pdfObjectives

After participating in this educational activity, attendees should be able to:
1. Recognize a case of new-onset atrial fibrillation in a critically ill patient based on presenting signs and symptoms.
2. Describe the role of amiodarone in new-onset atrial fibrillation in critical illness (NAFCI)
3. Evaluate current literature to recommend appropriate therapy in NAFCI.

Faculty

Kelly Nguyen, PharmD
PGY1 Pharmacy Resident
Pharmacist
Baystate Medical Center 

None of the members of the faculty and planning committee for this educational event have commercial relationships with any entity producing, marketing, re-selling or distributing health care goods and services consumed by or used on patients.